Cargando…

Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study

BACKGROUND: Benzodiazepine treatment recommendations for older adults differ markedly between guidelines, especially their advice on the acceptability of long-term use. AIMS: Using population-based data we compared risks associated with chronic versus intermittent benzodiazepine usage in older adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Simon JC, Rudoler, David, de Oliveira, Claire, Huang, Anjie, Kurdyak, Paul, Iaboni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066681/
https://www.ncbi.nlm.nih.gov/pubmed/35102786
http://dx.doi.org/10.1177/02698811211069096
_version_ 1784699845593792512
author Davies, Simon JC
Rudoler, David
de Oliveira, Claire
Huang, Anjie
Kurdyak, Paul
Iaboni, Andrea
author_facet Davies, Simon JC
Rudoler, David
de Oliveira, Claire
Huang, Anjie
Kurdyak, Paul
Iaboni, Andrea
author_sort Davies, Simon JC
collection PubMed
description BACKGROUND: Benzodiazepine treatment recommendations for older adults differ markedly between guidelines, especially their advice on the acceptability of long-term use. AIMS: Using population-based data we compared risks associated with chronic versus intermittent benzodiazepine usage in older adults. The primary outcome was falls resulting in hospital/emergency department visits. METHODS: We undertook a retrospective population-based cohort study using linked healthcare databases in adults aged ⩾ 66 years in Ontario, Canada, with a first prescription for benzodiazepines. Chronic and intermittent benzodiazepine users, based on the 180 days from index prescription, were matched (1:2 ratio) by sex, age and propensity score, then followed for up to 360 days. Hazard ratios (HRs) for outcomes were calculated from Cox regression models. RESULTS: A total of 57,041 chronic and 113,839 matched intermittent users were included. Hospitalization/emergency department visits for falls occurred during follow up in 4.6% chronic versus 3.2% intermittent users (HR = 1.13, 95% confidence interval (CI): 1.08 to 1.19; p < 0.0001). There were significant excess risks in chronic users for most secondary outcomes: hip fractures, hospitalizations/emergency department visits, long-term care admission and death, but not wrist fractures. Adjustment for benzodiazepine dosage had minimal impact on HRs. CONCLUSION: Our study demonstrates evidence of significant excess risks associated with chronic benzodiazepine use compared to intermittent use. The excess risks may inform decision-making by older adults and clinicians about whether short- or long-term benzodiazepine use is a reasonable option for symptom management.
format Online
Article
Text
id pubmed-9066681
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-90666812022-05-04 Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study Davies, Simon JC Rudoler, David de Oliveira, Claire Huang, Anjie Kurdyak, Paul Iaboni, Andrea J Psychopharmacol Original Papers BACKGROUND: Benzodiazepine treatment recommendations for older adults differ markedly between guidelines, especially their advice on the acceptability of long-term use. AIMS: Using population-based data we compared risks associated with chronic versus intermittent benzodiazepine usage in older adults. The primary outcome was falls resulting in hospital/emergency department visits. METHODS: We undertook a retrospective population-based cohort study using linked healthcare databases in adults aged ⩾ 66 years in Ontario, Canada, with a first prescription for benzodiazepines. Chronic and intermittent benzodiazepine users, based on the 180 days from index prescription, were matched (1:2 ratio) by sex, age and propensity score, then followed for up to 360 days. Hazard ratios (HRs) for outcomes were calculated from Cox regression models. RESULTS: A total of 57,041 chronic and 113,839 matched intermittent users were included. Hospitalization/emergency department visits for falls occurred during follow up in 4.6% chronic versus 3.2% intermittent users (HR = 1.13, 95% confidence interval (CI): 1.08 to 1.19; p < 0.0001). There were significant excess risks in chronic users for most secondary outcomes: hip fractures, hospitalizations/emergency department visits, long-term care admission and death, but not wrist fractures. Adjustment for benzodiazepine dosage had minimal impact on HRs. CONCLUSION: Our study demonstrates evidence of significant excess risks associated with chronic benzodiazepine use compared to intermittent use. The excess risks may inform decision-making by older adults and clinicians about whether short- or long-term benzodiazepine use is a reasonable option for symptom management. SAGE Publications 2022-02-01 2022-04 /pmc/articles/PMC9066681/ /pubmed/35102786 http://dx.doi.org/10.1177/02698811211069096 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Papers
Davies, Simon JC
Rudoler, David
de Oliveira, Claire
Huang, Anjie
Kurdyak, Paul
Iaboni, Andrea
Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
title Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
title_full Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
title_fullStr Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
title_full_unstemmed Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
title_short Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study
title_sort comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: a population-based cohort study
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066681/
https://www.ncbi.nlm.nih.gov/pubmed/35102786
http://dx.doi.org/10.1177/02698811211069096
work_keys_str_mv AT daviessimonjc comparativesafetyofchronicversusintermittentbenzodiazepineprescribinginolderadultsapopulationbasedcohortstudy
AT rudolerdavid comparativesafetyofchronicversusintermittentbenzodiazepineprescribinginolderadultsapopulationbasedcohortstudy
AT deoliveiraclaire comparativesafetyofchronicversusintermittentbenzodiazepineprescribinginolderadultsapopulationbasedcohortstudy
AT huanganjie comparativesafetyofchronicversusintermittentbenzodiazepineprescribinginolderadultsapopulationbasedcohortstudy
AT kurdyakpaul comparativesafetyofchronicversusintermittentbenzodiazepineprescribinginolderadultsapopulationbasedcohortstudy
AT iaboniandrea comparativesafetyofchronicversusintermittentbenzodiazepineprescribinginolderadultsapopulationbasedcohortstudy